Novo Nordisk A/S buy shnizdo
Start price
13.11.21
/
0%
€99.36
Target price
13.11.22
-
Performance (%)
10.69%
End price
14.07.22
€109.98
Summary
This prediction ended on 14.07.22 with a price of €109.98. The BUY prediction by shnizdo finished with a performance of 10.69%. Dividends of €6.90 are taken into consideration when calculating the performance. This prediction was marked as speculative and is excluded from shnizdo's performance statistics.Novo Nordisk is a Danish pharmaceutical company that specializes in diabetes care and research. It is considered to be one of the largest companies in the world that focus exclusively on diabetes management, with a product portfolio that ranges from insulin treatment to obesity management. The company is listed on the Copenhagen Stock Exchange and has gained global recognition for its commitment to sustainable business practices and its contribution to diabetes research and treatment. Novo Nordisk has a strong financial track record and has consistently delivered solid returns to investors over the years.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S | - | - | - |
| iShares Core DAX® | 0.597% | 3.083% | 16.090% |
| iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% |
| iShares Nikkei 225® | 1.775% | -1.206% | 6.823% |
| iShares S&P 500 | 0.990% | 3.500% | 24.956% |
Comments by shnizdo for this prediction
In the thread Novo Nordisk A/S diskutieren
Buy Novo Nordisk A/S